Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free PMVP Stock Alerts

PMV Pharmaceuticals (PMVP) SEC Filings & 10K Form

PMV Pharmaceuticals logo
$1.41 -0.01 (-0.70%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.42 +0.01 (+0.35%)
As of 02/21/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent PMV Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
9:06 AM		BML Investment Partners, L.P. (Filed by)
PMV Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
9:15 AM		BML Investment Partners, L.P. (Filed by)
PMV Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
11:58 AM		PMV Pharmaceuticals (Subject)
Sio Capital Management, LLC (Filed by)
Form SCHEDULE 13G
01/28/2025
3:58 PM		PMV Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/22/2025
3:37 PM		Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
11:29 AM		BML Investment Partners, L.P. (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
11/28/2024
11:15 PM		PMV Pharmaceuticals (Filer)
Form EFFECT
11/27/2024
3:43 PM		PMV Pharmaceuticals (Filer)
Form 424B3
11/20/2024
7:01 AM		PMV Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
11:24 AM		ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/12/2024
4:59 PM		Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:00 PM		Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2024
8:02 AM		PMV Pharmaceuticals (Subject)
Form SC TO-I
07/08/2024
3:32 PM		BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
06/10/2024
3:43 PM		LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:44 PM		PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:17 PM		FLOWERS KIRSTEN (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM		Gallagher Carol Giltner (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM		Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:32 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
7:00 AM		PMV Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
7:01 AM		PMV Pharmaceuticals (Filer)
Form DEFA14A
04/24/2024
7:02 AM		PMV Pharmaceuticals (Filer)
Form ARS
04/09/2024
12:17 PM		JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G/A
02/29/2024
3:05 PM		PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:05 PM		PMV Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:PMVP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored